This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Fleming, I. Search for Related Content PubMed Articles by Fleming, I. Related Collections Related Article

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1216.)
© 2008 American Heart Association, Inc.

Editorials

Double Tribble

Two TRIB3 Variants, Insulin, Akt, and eNOS

Ingrid Fleming

From the Vascular Signalling Group, Institut für Kardiovaskuläre Physiologie, Goethe-Universität Frankfurt am Main, Germany.

Correspondence to Ingrid Fleming, PhD, Vascular Signalling Group, Institut für Kardiovaskuläre Physiologie, Goethe-Universität Frankfurt am Main, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany. E-mail fleming@em.uni-frankfurt.de

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Insulin signaling under normal physiological conditions as well as its disruption in response to oxidative stress represents a field of intense research interest. It is generally accepted that insulin, on binding to its receptor, initiates the tyrosine phosphorylation of cellular substrates including the insulin receptor substrate (IRS) family members, which in turn modulate the activation of the phosphatidylinositol 3-kinase (PI 3-K) and downstream kinases such as PKC and Akt, which are responsible for initiating a number of cellular effects.¹ It follows that defects in this signaling cascade lead to an altered cellular responsiveness to insulin and to insulin resistance, the earliest detectable abnormality in the development of diabetes.

See accompanying article on page 1355

Recently, a protein called TRIB3, a mammalian tribbles homolog also known as TRB3/NIPK, was reported to interfere with insulin signaling by binding to and inhibiting the serine kinase Akt.^2,3 TRIB3 expression can be increased by several stimuli including starvation,² PPAR- activation,³ and chronic alcohol ingestion,⁴ and in all of the conditions listed is linked to insulin insensitivity. Moreover, a relatively frequent (minor allele frequency 15%) missense TRIB3 polymorphism has also been described in which a glutamine residue is substituted by an arginine at position 84 (Q84R), to result in a protein that more readily binds to the pleckstrin homology domain of Akt to prevent its plasma membrane association. Overexpression of this TRIB3 variant in a cell line moderately decreases (22%) the insulin-induced phosphorylation and activation of Akt.⁵

In this issue of Arteriosclerosis, Thrombosis, and Vascular . . . [Full Text of this Article]

Related Article:

TRIB3 R84 Variant Is Associated With Impaired Insulin-Mediated Nitric Oxide Production in Human Endothelial Cells

Francesco Andreozzi, Gloria Formoso, Sabrina Prudente, Marta Letizia Hribal, Assunta Pandolfi, Emanuele Bellacchio, Sara Di Silvestre, Vincenzo Trischitta, Agostino Consoli, and Giorgio Sesti
Arterioscler Thromb Vasc Biol 2008 28: 1355-1360. [Abstract] [Full Text] [PDF]